An Australian medicinal cannabis company is working to address a global shortage of pharmaceutical-grade product, reducing cost and improving access at the same time.
With Australian doctors' ongoing reluctance to prescribe it to patients, the nation's fledgling medicinal cannabis industry is eyeing off the export markets in its bid to take off.
Months behind schedule, Queensland's first licensed medicinal cannabis farm has started growing plants with the aim of manufacturing medicines from early next year.
The Coca-Cola Company says it is "closely watching" the expanding use of a cannabis element in drinks, another sign the controversial product is getting more acceptance in mainstream culture.
Key players in industrial hemp say Australia is missing the opportunity to develop a nutraceuticals industry derived from cannabis plant.
Brisbane City Council has given the tick to a plan for a cannabis farm in the city's west, but nearby residents appear to know nothing about it.
A father who escaped jail time for juicing cannabis to treat his two daughters who suffer Crohn's disease is now considering sending one of them overseas for treatment.
Scientists push for more research into whether the chemical in cannabis which causes a high should be included in small quantities in legal medicinal cannabis products for children with severe epilepsy.
Almost two-thirds of Australian GPs have had patients ask about medicinal cannabis, but research reveals most doctors feel their knowledge of the drug is inadequate and they are not comfortable discussing it with patients.
Psychotic disorders are severe mental health condition and there's consistent evidence showing a link between heavy or repeated cannabis use and an experience of psychosis for the first time, write Jerome Sarris and Joe Firth.